Yüklüyor......
Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile
BACKGROUND: Irritable bowel syndrome is classified as a functional gastrointestinal disorder with the primary symptom of abdominal pain in conjunction with bloating and bowel movement disorder. It affects up to 15% of the world’s population. Among its subtypes, the most common is diarrhoea predomina...
Kaydedildi:
| Yayımlandı: | Clin Med Insights Gastroenterol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5582649/ https://ncbi.nlm.nih.gov/pubmed/28894393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179552217728905 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|